Stefanos Theoharis, PhD, was appointed chief business officer of Bone Therapeutics on March 26. By Alan Condon - 3/27/20

Zolgensma, Novartis' gene therapy drug for spinal muscular atrophy, recently demonstrated significant therapeutic benefits for patients in various extended clinical trials, reports Pharmaceutical Technology. By Alan Condon - 3/26/20

The Japanese Ministry of Health, Labour and Welfare recently approved Zolgensma, Novartis' gene therapy drug for the treatment of spinal muscular atrophy, for infants under the age of 2, according to Medical Dialogues. By Alan Condon - 3/23/20

Regenerative medicine therapies hold much potential in the orthopedic space, despite the lack of comprehensive knowledge around the therapies. Here, Anika Therapeutics interim CEO Cheryl Blanchard, PhD, explains how the company plans to approach the biologics market. By Eric Oliver - 3/19/20

SpineOvations on Feb 24. finished enrollment for its DiscSeal clinical study in patients suffering from lumbar pain. By Alan Condon - 2/24/20

Roger Härtl, MD, has devoted much of his career to finding the best, least invasive treatment for back and neck pain. That mission has led him to research and innovate in the field of spinal biologics. By Laura Dyrda - 2/24/20

Konica Minolta Healthcare Americas partnered with RegenLab USA Feb. 19 to distribute its regenerative medicine portfolio for the orthopedic market in the U.S. and Canada. By Alan Condon - 2/21/20

Early-stage research published in npg Regenerative Medicine demonstrated that two medications on the market can enhance the body's ability to heal by releasing stem cells from bone marrow, reports Science Blog. By Alan Condon - 2/21/20

Neel Anand, MD, serves as professor of orthopedic surgery and director of spine trauma at the Cedars-Sinai Spine Center in Los Angeles. By Alan Condon - 2/20/20

Biopharmaceutical company MicroCures partnered Feb. 19 with the Henry M. Jackson Foundation for the Advancement of Military Medicine to study spinal cord regeneration after trauma. By Alan Condon - 2/19/20

Steven Cyr, MD, is a fellowship-trained spine surgeon who recently began providing stem cell treatments at SASpine in San Antonio. By Alan Condon - 2/17/20

Frank Phillips, MD, is the director of the section of minimally invasive spine surgery and director of the division of spine surgery at Chicago-based Rush University Medical Center. By Laura Dyrda - 2/17/20

Several clinical trials in China have been put on hold due to the coronavirus outbreak, including a treatment for a type of spondyloarthritis, according to Reuters. By Alan Condon - 2/13/20

This year marks the 15th anniversary of orthobiologic physician group Regenexx. By Alan Condon - 2/12/20

Onkos Surgical on Feb. 6 launched GenVie Magnesium Bone Scaffold, a magnesium-based bone void filler for orthopedic conditions. By Alan Condon - 2/7/20

Zolgensma, a gene therapy drug for spinal muscular atrophy, has been on the market since June 2019 and is widely reported to be the most expensive drug in the world. By Alan Condon - 2/3/20

Steven Cyr, MD, is now providing stem cell treatments at SASpine in San Antonio. By Alan Condon - 2/3/20

Myeliviz, a new drug to help diagnose multiple sclerosis in its earlier stages was recently approved by the FDA for human clinical trials. By Alan Condon - 1/29/20

Zolgensma, Novartis' gene therapy drug for spinal muscular atrophy, totaled $186 million in fourth quarter sales, according to Stat. By Alan Condon - 1/29/20

Here are eight things to know about the spinal fusion market. By Laura Dyrda - 1/28/20